title: MMP-9 and CXCL8/IL-8 are potential therapeutic targets in epidermolysis bullosa simplex.
abstract: Epidermolysis bullosa refers to a group of genodermatoses that affects the integrity of epithelial layers, phenotypically resulting in severe skin blistering. Dowling-Meara, the major subtype of epidermolysis bullosa simplex, is inherited in an autosomal dominant manner and can be caused by mutations in either the keratin-5 (K5) or the keratin-14 (K14) gene. Currently, no therapeutic approach is known, and the main objective of this study was to identify novel therapeutic targets. We used microarray analysis, semi-quantitative real-time PCR, western blot and ELISA to identify differentially regulated genes in two K14 mutant cell lines carrying the mutations K14 R125P and K14 R125H, respectively. We found kallikrein-related peptidases and matrix metalloproteinases to be upregulated. We also found elevated expression of chemokines, and we observed deregulation of the Cdc42 pathway as well as aberrant expression of cytokeratins and junction proteins. We further demonstrated, that expression of these genes is dependent on interleukin-1 β signaling. To evaluate these data in vivo we analysed the blister fluids of epidermolysis bullosa simplex patients vs. healthy controls and identified matrix metalloproteinase-9 and the chemokine CXCL8/IL-8 as potential therapeutic targets.
authors.affiliation: Division of Experimental Dermatology and EB House Austria, Salzburg, Austria. thomas.lettner@gmail.com
authors.forename: Thomas
authors.initials: T
authors.lastname: Lettner
authors.forename: Roland
authors.initials: R
authors.lastname: Lang
authors.forename: Alfred
authors.initials: A
authors.lastname: Klausegger
authors.forename: Stefan
authors.initials: S
authors.lastname: Hainzl
authors.forename: Johann W
authors.initials: JW
authors.lastname: Bauer
authors.forename: Verena
authors.initials: V
authors.lastname: Wally
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D002461:Cell Line, Transformed; D002648:Child; D002675:Child, Preschool; D017630:Connexins / Q000235:genetics / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism; D016110:Epidermolysis Bullosa Simplex / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D020869:Gene Expression Profiling; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007223:Infant; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors; D016209:Interleukin-8 / Q000235:genetics / Q000378:metabolism*; D007610:Kallikreins / Q000235:genetics / Q000378:metabolism; D007633:Keratins / Q000235:genetics / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000235:genetics / Q000378:metabolism*; D008565:Membrane Proteins / Q000378:metabolism; D008875:Middle Aged; D009154:Mutation; D010766:Phosphorylation; D064067:Rho Guanine Nucleotide Exchange Factors / Q000235:genetics / Q000378:metabolism; D055815:Young Adult; D020764:cdc42 GTP-Binding Protein / Q000378:metabolism; D000099149:Ezrin
chemical_list: D000911:Antibodies, Monoclonal; D017630:Connexins; D003598:Cytoskeletal Proteins; D053583:Interleukin-1beta; D016209:Interleukin-8; D007610:Kallikreins; D007633:Keratins; D020780:Matrix Metalloproteinase 9; D008565:Membrane Proteins; D064067:Rho Guanine Nucleotide Exchange Factors; D020764:cdc42 GTP-Binding Protein; D000099149:Ezrin; C577410:ARHGEF9 protein, human; C071776:radixin
references.citation: Physiol Rev. 2001 Jan;81(1):153-208
references.pmid: 11152757
references.citation: Int J Biol Sci. 2011;7(6):782-91
references.pmid: 21750647
references.citation: Arch Dermatol. 1999 Aug;135(8):997-8
references.pmid: 10456363
references.citation: J Invest Dermatol. 2013 Jul;133(7):1901-3
references.pmid: 23344459
references.citation: J Cell Sci. 1999 Sep;112 ( Pt 17):2983-92
references.pmid: 10444392
references.citation: Br J Dermatol. 2003 Jul;149(1):46-58
references.pmid: 12890194
references.citation: Arch Dermatol. 2000 Mar;136(3):424-5
references.pmid: 10724216
references.citation: J Invest Dermatol. 2004 May;122(5):1235-44
references.pmid: 15140227
references.citation: J Cell Sci. 2012 Jun 15;125(Pt 12):2853-61
references.pmid: 22454510
references.citation: J Invest Dermatol. 2007 Dec;127(12):2781-9
references.pmid: 17581617
references.citation: J Invest Dermatol. 2003 Dec;121(6):1291-300
references.pmid: 14675172
references.citation: Biochem J. 1999 Mar 1;338 ( Pt 2):387-92
references.pmid: 10024514
references.citation: Hum Mol Genet. 2010 Dec 1;19(23):4715-25
references.pmid: 20861136
references.citation: J Invest Dermatol. 2001 May;116(5):633-40
references.pmid: 11348449
references.citation: Mol Cell Biol. 1998 Jan;18(1):130-40
references.pmid: 9418861
references.citation: J Mammary Gland Biol Neoplasia. 2007 Sep;12(2-3):143-52
references.pmid: 17557195
references.citation: Eur J Dermatol. 2011 Nov-Dec;21(6):966-71
references.pmid: 21856558
references.citation: Exp Cell Res. 2009 Oct 15;315(17):2995-3003
references.pmid: 19616543
references.citation: J Cell Physiol. 2007 Jul;212(1):36-41
references.pmid: 17311292
references.citation: Br J Dermatol. 2004 May;150(5):878-91
references.pmid: 15149499
references.citation: Genome Biol. 2009;10(6):226
references.pmid: 19589182
references.citation: J Clin Invest. 1997 Sep 1;100(5):1256-63
references.pmid: 9276744
references.citation: Eur J Oral Sci. 2001 Feb;109(1):50-9
references.pmid: 11330935
references.citation: Nat Protoc. 2009;4(1):44-57
references.pmid: 19131956
references.citation: Genes Cells. 2000 Jul;5(7):571-81
references.pmid: 10947843
references.citation: Am J Physiol Cell Physiol. 2010 Sep;299(3):C539-48
references.pmid: 20592239
references.citation: J Am Acad Dermatol. 2008 Jun;58(6):931-50
references.pmid: 18374450
references.citation: J Cell Sci. 2004 Oct 15;117(Pt 22):5233-43
references.pmid: 15454576
references.citation: Curr Opin Cell Biol. 2000 Feb;12(1):91-6
references.pmid: 10679362
references.citation: Mol Biol Cell. 2007 Aug;18(8):2935-48
references.pmid: 17538024
references.citation: J Invest Dermatol. 2010 Mar;130(3):671-81
references.pmid: 19847192
references.citation: J Cell Biol. 1995 Jun;129(5):1329-44
references.pmid: 7539810
references.citation: Circ Res. 2003 May 2;92(8):827-39
references.pmid: 12730128
references.citation: Nat Neurosci. 2000 Jan;3(1):22-9
references.pmid: 10607391
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Nat Genet. 2001 Dec;29(4):365-71
references.pmid: 11726920
references.citation: J Dermatol. 2011 Dec;38(12):1177-9
references.pmid: 21967011
references.citation: Histochem Cell Biol. 2008 Jun;129(6):705-33
references.pmid: 18461349
references.citation: J Biol Chem. 1995 Nov 24;270(47):27995-8
references.pmid: 7499279
references.citation: J Clin Invest. 2009 Jul;119(7):1784-93
references.pmid: 19587453
references.citation: Clin Exp Immunol. 2001 Apr;124(1):157-62
references.pmid: 11359455
references.citation: Exp Dermatol. 2012 Feb;21(2):111-7
references.pmid: 22168818